Carl-Fredrik Wahlgren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Carl-Fredrik Wahlgren has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Maria Bradley
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
4 shared publications - Anna Bergström
Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
3 shared publications - Inger Kull
Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet Stockholm Sweden
3 shared publications - Magnus Nordenskjöld
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden
3 shared publications - Emma Kristin Johansson
Karolinska Institutet
2 shared publications - Isabel Tapia-Páez
Division of Dermatology and Venereology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
2 shared publications
Latest Publications
- Open Access
- 27 January 2026
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106, adv43770
The Role of the Cysteamine Dioxygenase (ADO) Gene in Atopic Dermatitis
Atopic dermatitis is a chronic inflammatory skin disorder influenced by genetic and environmental factors. A chromosome conformation capture study identified the cysteamine dioxygenase (ADO) gene as being associated with atopic dermatitis in differentiating keratinocytes. We aimed to evaluate the causal and pathophysiological roles of ADO in atopic dermatitis. This study utilized transcriptomic data and immunostaining techniques to analyse ADO expression. Human keratinocyte cell line (HaCat), and zebrafish models were employed to explore the functional role of ADO. RNA sequencing and immunostainings indicated higher ADO expression in lesional skin than in non-lesional skin in atopic dermatitis patients. Moreover, atopic dermatitis patients carrying the risk allele (C) exhibited increased levels of ADO in lesional skin. In vivo, zebrafish embryos with dysregulated ADO expression displayed impaired epidermal morphogenesis, particularly in their tails, along with increased neutrophil infiltration, indicating an inflammatory response. In vitro, alterations in ADO expression in HaCaT cells led to expression changes of proinflammatory cytokines and skin barrier markers. Further, both upregulation and downregulation of ADO were associated with enhanced reactive oxygen species production. These findings suggest that the ADO gene plays a critical role in maintaining skin homeostasis, and its dysregulation contributes to inflammation and compromised skin barrier function in the pathogenesis of atopic dermatitis.
- 27 January 2026
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106, adv43770
Open AccessThe Role of the Cysteamine Dioxygenase (ADO) Gene in Atopic Dermatitis
Atopic dermatitis is a chronic inflammatory skin disorder influenced by genetic and environmental factors. A chromosome conformation capture study identified the cysteamine dioxygenase (ADO) gene as being associated with atopic dermatitis in differentiating keratinocytes. We aimed to evaluate the causal and pathophysiological roles of ADO in atopic dermatitis. This study utilized transcriptomic data and immunostaining techniques to analyse ADO expression. Human keratinocyte cell line (HaCat), and zebrafish models were employed to explore the functional role of ADO. RNA sequencing and immunostainings indicated higher ADO expression in lesional skin than in non-lesional skin in atopic dermatitis patients. Moreover, atopic dermatitis patients carrying the risk allele (C) exhibited increased levels of ADO in lesional skin. In vivo, zebrafish embryos with dysregulated ADO expression displayed impaired epidermal morphogenesis, particularly in their tails, along with increased neutrophil infiltration, indicating an inflammatory response. In vitro, alterations in ADO expression in HaCaT cells led to expression changes of proinflammatory cytokines and skin barrier markers. Further, both upregulation and downregulation of ADO were associated with enhanced reactive oxygen species production. These findings suggest that the ADO gene plays a critical role in maintaining skin homeostasis, and its dysregulation contributes to inflammation and compromised skin barrier function in the pathogenesis of atopic dermatitis.
- Open Access
- 29 April 2024
- Published by Elsevier in JID Innovations
- Vol. 4 (4)
Uncommon Variants in FLG2 and NOD2 Are Associated with Atopic Dermatitis in the Ethiopian Population
- 29 April 2024
- Published by Elsevier in JID Innovations
- Vol. 4 (4)
Open AccessUncommon Variants in FLG2 and NOD2 Are Associated with Atopic Dermatitis in the Ethiopian Population
- 1 September 2019
- Published by Elsevier in European Journal of Cancer
- Vol. 118, 149-155
Future reduction of cutaneous malignant melanoma due to improved sun protection habits and decreased common melanocytic nevi density among Swedish children?
- 1 September 2019
- Published by Elsevier in European Journal of Cancer
- Vol. 118, 149-155
Future reduction of cutaneous malignant melanoma due to improved sun protection habits and decreased common melanocytic nevi density among Swedish children?
- 22 November 2018
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 180 (4) , 782-789
Atopic dermatitis at preschool age and contact allergy in adolescence: a population‐based cohort study
Background Atopic dermatitis (AD) is characterized by an impaired skin barrier that can allow enhanced penetration of allergens. It is not clear whether AD influences the risk of developing contact allergy. Objectives To examine the association between AD at preschool age and contact allergy at 16 years of age. Methods At 16 years of age, 2215 adolescents from the population‐based cohort BAMSE were included. These adolescents had been followed with repeated questionnaires regarding AD throughout childhood, and contact allergy was assessed by skin patch test at 16 years. Results AD at preschool age was associated with contact allergy to at least one of the tested substances at 16 years of age among boys (adjusted odds ratio [OR] 1.51, 95% confidence interval 1.03‐2.20), but not among girls (adjusted OR 0.77, 95% CI 0.54‐1.10). AD at preschool age was not associated with contact allergy to nickel in either boys or girls. In contrast, AD at preschool age was associated with contact allergy to fragrance mix I (adjusted OR 3.10, 95% CI 1.66‐5.80). This association was observed especially for AD at preschool age in combination with immunoglobulin E (IgE) sensitization to airborne or food allergens (adjusted OR 3.80, 95% CI 1.67‐8.61). Conclusions The results suggest that AD in early childhood may be associated with contact allergy to fragrances, but not to nickel, in adolescence.
- 22 November 2018
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 180 (4) , 782-789
Atopic dermatitis at preschool age and contact allergy in adolescence: a population‐based cohort study
Background Atopic dermatitis (AD) is characterized by an impaired skin barrier that can allow enhanced penetration of allergens. It is not clear whether AD influences the risk of developing contact allergy. Objectives To examine the association between AD at preschool age and contact allergy at 16 years of age. Methods At 16 years of age, 2215 adolescents from the population‐based cohort BAMSE were included. These adolescents had been followed with repeated questionnaires regarding AD throughout childhood, and contact allergy was assessed by skin patch test at 16 years. Results AD at preschool age was associated with contact allergy to at least one of the tested substances at 16 years of age among boys (adjusted odds ratio [OR] 1.51, 95% confidence interval 1.03‐2.20), but not among girls (adjusted OR 0.77, 95% CI 0.54‐1.10). AD at preschool age was not associated with contact allergy to nickel in either boys or girls. In contrast, AD at preschool age was associated with contact allergy to fragrance mix I (adjusted OR 3.10, 95% CI 1.66‐5.80). This association was observed especially for AD at preschool age in combination with immunoglobulin E (IgE) sensitization to airborne or food allergens (adjusted OR 3.80, 95% CI 1.67‐8.61). Conclusions The results suggest that AD in early childhood may be associated with contact allergy to fragrances, but not to nickel, in adolescence.
- Open Access
- 17 September 2018
- Published by Wiley in British Journal of Dermatology
- Vol. 179 (3) , e141
Emollients and topical glucocorticoids in adolescents with eczema
- 17 September 2018
- Published by Wiley in British Journal of Dermatology
- Vol. 179 (3) , e141
Open AccessEmollients and topical glucocorticoids in adolescents with eczema
- 25 February 2018
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 179 (3) , 709-716
Use of emollients and topical glucocorticoids among adolescents with eczema: data from the population-based birth cohort BAMSE
Background Knowledge regarding how adolescents treat their eczema is sparse. Objectives To explore the use of emollients and topical glucocorticoids in adolescents with eczema in relation to sex and disease severity, and to study dispensing patterns of topical glucocorticoids. Methods Questionnaire-based data on symptoms of eczema, eczema severity and treatment with emollients and topical glucocorticoids were obtained from 3108 adolescents in the Swedish population-based birth cohort BAMSE. Severity of reported eczema was evaluated with the BAMSE Eczema Severity Score (BESS) in a questionnaire and with the Patient-Oriented Eczema Measure in clinically examined patients with current eczema (n = 247). Information on dispensed topical glucocorticoids was obtained from the Swedish Prescribed Drug Register. Results In all, 10% of the adolescents reported eczema in the preceding year: 73% mild, 17% moderate and 10% severe according to BESS. Almost all used emollients, whereas use of topical glucocorticoids was reported by 55%, with no significant difference between sexes. The likelihood of treatment with emollients and topical glucocorticoids increased when the adolescents had symptoms of current eczema [adjusted odds ratio (OR) 5·95, 95% confidence interval (CI) 1·90–18·8], but not if they had more severe eczema compared with mild eczema (adjusted OR 1·57, 95% CI 0·58–4·25). Among those with reported eczema, 24% had a topical glucocorticoid dispensed in the preceding year, and among those with moderate-to-severe current eczema 24% had a dispensed potent topical glucocorticoid. Conclusions This population-based study indicates that adolescents with eczema are undertreated or completely untreated, even those with severe eczema.
- 25 February 2018
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 179 (3) , 709-716
Use of emollients and topical glucocorticoids among adolescents with eczema: data from the population-based birth cohort BAMSE
Background Knowledge regarding how adolescents treat their eczema is sparse. Objectives To explore the use of emollients and topical glucocorticoids in adolescents with eczema in relation to sex and disease severity, and to study dispensing patterns of topical glucocorticoids. Methods Questionnaire-based data on symptoms of eczema, eczema severity and treatment with emollients and topical glucocorticoids were obtained from 3108 adolescents in the Swedish population-based birth cohort BAMSE. Severity of reported eczema was evaluated with the BAMSE Eczema Severity Score (BESS) in a questionnaire and with the Patient-Oriented Eczema Measure in clinically examined patients with current eczema (n = 247). Information on dispensed topical glucocorticoids was obtained from the Swedish Prescribed Drug Register. Results In all, 10% of the adolescents reported eczema in the preceding year: 73% mild, 17% moderate and 10% severe according to BESS. Almost all used emollients, whereas use of topical glucocorticoids was reported by 55%, with no significant difference between sexes. The likelihood of treatment with emollients and topical glucocorticoids increased when the adolescents had symptoms of current eczema [adjusted odds ratio (OR) 5·95, 95% confidence interval (CI) 1·90–18·8], but not if they had more severe eczema compared with mild eczema (adjusted OR 1·57, 95% CI 0·58–4·25). Among those with reported eczema, 24% had a topical glucocorticoid dispensed in the preceding year, and among those with moderate-to-severe current eczema 24% had a dispensed potent topical glucocorticoid. Conclusions This population-based study indicates that adolescents with eczema are undertreated or completely untreated, even those with severe eczema.
- Open Access
- 30 March 2015
- Published by International Journal of Medical Education in International Journal of Medical Education
- Vol. 6, 40-46
A phenomenographic study of students' conception of learning for a written examination
We investigated students’ conception of learning for an examination in internal medicine, infec-tious diseases and dermatology-venereology, in three separate examinations versus a single integrated one.
- 30 March 2015
- Published by International Journal of Medical Education in International Journal of Medical Education
- Vol. 6, 40-46
Open AccessA phenomenographic study of students' conception of learning for a written examination
We investigated students’ conception of learning for an examination in internal medicine, infec-tious diseases and dermatology-venereology, in three separate examinations versus a single integrated one.
- 3 May 2012
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 304 (10) , 773-780
Characterization of EGFR and ErbB2 expression in atopic dermatitis patients
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases in industrialized countries. To identify candidate genes involved in the pathogenesis of AD, we previously undertook a genome-wide approach using DNA microarrays. A transcript encoding the epidermal growth factor receptor (EGFR) was found to be among the down-regulated transcripts in AD skin. Here, we further investigated the expression pattern of two EGFR family members (EGFR and ErbB2) in AD skin on a protein level. Immunohistochemical (IHC) analysis of EGFR and ErbB2 showed decreased expression of EGFR and ErbB2 proteins in AD lesional skin as compared to skin from healthy individuals. Interestingly, we found that EGFR and ErbB2 were reciprocally expressed in an in vitro model of keratinocyte proliferation and differentiation, paralleling the expression patterns found in epidermis of healthy skin. The highest levels of EGFR transcripts were found in proliferating cells, while ErbB2 was found in differentiated cells. We show that blocking EGFR activity combined with co-stimulation of the Th2-cytokine IL4 in keratinocytes leads to induction of the inflammatory chemokine CCL26/eotaxin-3 in vitro. Accordingly, increased CCL26 transcriptional levels were observed in AD lesional skin. Taken together, suppression of EGFR may contribute to the pathogenesis of AD via the regulation of inflammatory chemokines.
- 3 May 2012
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 304 (10) , 773-780
Characterization of EGFR and ErbB2 expression in atopic dermatitis patients
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases in industrialized countries. To identify candidate genes involved in the pathogenesis of AD, we previously undertook a genome-wide approach using DNA microarrays. A transcript encoding the epidermal growth factor receptor (EGFR) was found to be among the down-regulated transcripts in AD skin. Here, we further investigated the expression pattern of two EGFR family members (EGFR and ErbB2) in AD skin on a protein level. Immunohistochemical (IHC) analysis of EGFR and ErbB2 showed decreased expression of EGFR and ErbB2 proteins in AD lesional skin as compared to skin from healthy individuals. Interestingly, we found that EGFR and ErbB2 were reciprocally expressed in an in vitro model of keratinocyte proliferation and differentiation, paralleling the expression patterns found in epidermis of healthy skin. The highest levels of EGFR transcripts were found in proliferating cells, while ErbB2 was found in differentiated cells. We show that blocking EGFR activity combined with co-stimulation of the Th2-cytokine IL4 in keratinocytes leads to induction of the inflammatory chemokine CCL26/eotaxin-3 in vitro. Accordingly, increased CCL26 transcriptional levels were observed in AD lesional skin. Taken together, suppression of EGFR may contribute to the pathogenesis of AD via the regulation of inflammatory chemokines.
- 8 December 2009
- Vol. 106 (43) , 2754-7
[Congenital melanocytic nevi in children. The level of knowledge and management suggestions].
- 8 December 2009
- Vol. 106 (43) , 2754-7
[Congenital melanocytic nevi in children. The level of knowledge and management suggestions].